Structural Insights into Antibody Recognition of Mycobacterial Polysaccharides

Journal of Molecular Biology

Volumn 392, Issue 2, 2009, Pages 381-392

  Murase, Tomohiko ^a   Zheng, Ruixiang Blake ^a,b   Joe, Maju ^a,b   Bai, Yu ^a,b   Marcus, Sandra L ^b   Lowary, Todd L ^a,b   Ng, Kenneth K S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

carbohydrate antibody complex; lipoarabinomannan; mycobacteria; oligofuranoside; X ray crystallography

Indexed keywords

EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; LIPOARABINOMANNAN; TETRASACCHARIDE;

ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BACTERIAL CELL WALL; BACTERIAL VIRULENCE; BINDING SITE; CARBOHYDRATE ANALYSIS; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG RESEARCH; EVOLUTIONARY ADAPTATION; IMMUNOMODULATION; LEPROSY; MOLECULAR RECOGNITION; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; X RAY CRYSTALLOGRAPHY;

CORYNEBACTERINEAE; MURINAE;

EID: 68949211703     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.06.074     Document Type: Article

References (53)

1. Davies P.D. The world-wide increase in tuberculosis: how demographic changes, HIV infection and increasing numbers in poverty are increasing tuberculosis. Ann. Med. 35 (2003) 235-243
2. Coker R.J. Review: Multidrug-resistant tuberculosis: public health challenges. Trop. Med. Int. Health 9 (2004) 25-40
3. de Jong B.C., Israelski D.M., Corbett E.L., and Small P.M. Clinical management of tuberculosis in the context of HIV infection. Annu. Rev. Med. 55 (2004) 283-301
4. Nachega J.B., and Chaisson R.E. Tuberculosis drug resistance: a global threat. Clin. Infect. Dis. 36 (2003) S24-S30
5. Young D.B., Perkins M.D., Duncan K., and Barry III C.E. Confronting the scientific obstacles to global control of tuberculosis. J. Clin. Invest. 118 (2008) 1255-1265
6. Brennan P.J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinburgh) 83 (2003) 91-97
7. Nigou J., Gilleron M., and Puzo G. Lipoarabinomannans: from structure to biosynthesis. Biochimie 85 (2003) 153-166
8. Briken V., Porcelli S.A., Besra G.S., and Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53 (2004) 391-403
9. Shi L., Berg S., Lee A., Spencer J.S., Zhang J., Vissa V., et al. The carboxy terminus of EmbC from Mycobacterium smegmatis mediates chain length extension of the arabinan in lipoarabinomannan. J. Biol. Chem. 281 (2006) 19512-19526
10. Chatterjee D., Lowell K., Rivoire B., McNeil M.R., and Brennan P.J. Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J. Biol. Chem. 267 (1992) 6234-6239
11. Appelmelk B.J., den Dunnen J., Driessen N.N., Ummels R., Pak M., Nigou J., et al. The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell. Microbiol. 10 (2008) 930-944
12. Khoo K.H., Dell A., Morris H.R., Brennan P.J., and Chatterjee D. Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: definition of a common anchor for lipomannan and lipoarabinomannan. Glycobiology 5 (1995) 117-127
13. Treumann A., Xidong F., McDonnell L., Derrick P.J., Ashcroft A.E., Chatterjee D., and Homans S.W. 5-Methylthiopentose: a new substituent on lipoarabinomannan in Mycobacterium tuberculosis. J. Mol. Biol. 316 (2002) 89-100
14. Ludwiczak P., Gilleron M., Bordat Y., Martin C., Gicquel B., and Puzo G. Mycobacterium tuberculosis phoP mutant: lipoarabinomannan molecular structure. Microbiology 148 (2002) 3029-3037
15. Joe M., Sun D., Taha H., Completo G.C., Croudace J.E., Lammas D.A., et al. The 5-deoxy-5-methylthio-xylofuranose residue in mycobacterial lipoarabinomannan. Absolute stereochemistry, linkage position, conformation, and immunomodulatory activity. J. Am. Chem. Soc. 128 (2006) 5059-5072
16. Stalford S.A., Fascione M.A., Sasindran S.J., Chatterjee D., Dhandayuthapani S., and Turnbull W.B. A natural carbohydrate substrate for Mycobacterium tuberculosis methionine sulfoxide reductase A. Chem. Commun. (Cambridge) (2009) 110-112
17. Tong M., Jacobi C.E., van de Rijke F.M., Kuijper S., van de Werken S., Lowary T.L., et al. A multiplexed and miniaturized serological tuberculosis assay identifies antigens that discriminate maximally between TB and non-TB sera. J. Immunol. Methods 301 (2005) 154-163
18. Arias-Bouda L.M.P., Kuijper S., van Deutekom H., van Gijlswijk R., Pekel I., Jansen H.M., and Kolk A.H. Enzyme-linked immunosorbent assays using immune complexes for the diagnosis of tuberculosis. J. Immunol. Methods 283 (2003) 115-124
19. Verbon A., Kuijper S., Jansen H.M., Speelman P., and Kolk A.H. Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies. J. Gen. Microbiol. 136 (1990) 955-964
20. Hunter S.W., Gaylord H., and Brennan P.J. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J. Biol. Chem. 261 (1986) 12345-12351
21. Kaur D., Lowary T.L., Vissa V.D., Crick D.C., and Brennan P.J. Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans. Microbiology 148 (2002) 3049-3057
22. Rademacher C., Shoemaker G.K., Kim H.S., Zheng R.B., Taha H., Liu C., et al. Ligand specificity of CS-35, a monoclonal antibody that recognizes mycobacterial lipoarabinomannan: a model system for oligofuranoside-protein recognition. J. Am. Chem. Soc. 129 (2007) 10489-10502
23. Abhinandan K.R., and Martin A.C. Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains. Mol. Immunol. 45 (2008) 3832-3839
24. Pal D., and Chakrabarti P. Cis peptide bonds in proteins: residues involved, their conformations, interactions and locations. J. Mol. Biol. 294 (1999) 271-288
25. Jabs A., Weiss M.S., and Hilgenfeld R. Non-proline cis peptide bonds in proteins. J. Mol. Biol. 286 (1999) 291-304
26. Bates P.A., Dokurno P., Freemont P.S., and Sternberg M.J. Conformational analysis of the first observed non-proline cis-peptide bond occurring within the complementarity determining region (CDR) of an antibody. J. Mol. Biol. 284 (1998) 549-555
27. Dokurno P., Bates P.A., Band H.A., Stewart L.M., Lally J.M., Burchell J.M., et al. Crystal structure at 1.95 Å resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition. J. Mol. Biol. 284 (1998) 713-728
28. Cygler M., Rose D.R., and Bundle D.R. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science 253 (1991) 442-445
29. Altona C., and Sundaralingam M. Conformational analysis of the sugar ring in nucleosides and nucleotides. A new description using the concept of pseudorotation. J. Am. Chem. Soc. 94 (1972) 8205-8212
30. de Leeuw F.A.A.M., and Altona C. Computer-assisted pseudorotation analysis of five-membered rings by means of proton spin-spin coupling constants: program PSEUROT. J. Comput. Chem. 4 (1983) 428-437
31. Nurizzo D., Turkenburg J.P., Charnock S.J., Roberts S.M., Dodson E.J., McKie V.A., et al. Cellvibrio japonicus α-l-arabinanase 43A has a novel five-blade β-propeller fold. Nat. Struct. Biol. 9 (2002) 665-668
32. Kang P.B., Azad A.K., Torrelles J.B., Kaufman T.M., Beharka A., Tibesar E., et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med. 202 (2005) 987-999
33. Orme I.M. Preclinical testing of new vaccines for tuberculosis: a comprehensive review. Vaccine 24 (2006) 2-19
34. Glatman-Freedman A. The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy. Tuberculosis (Edinburgh) 86 (2006) 191-197
35. Kallenius G., Pawlowski A., Hamasur B., and Svenson S.B. Mycobacterial glycoconjugates as vaccine candidates against tuberculosis. Trends Microbiol. 16 (2008) 456-462
36. Hamasur B., Haile M., Pawlowski A., Schroder U., Williams A., Hatch G., et al. Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis. Vaccine 21 (2003) 4081-4093
37. Maruyama C. Studies on the treatment of skin tuberculosis with extracts from tubercle bacilli. Jpn. J. Dermatol. 74 (1964) 139-164
38. Maruyama C., Watanabe Y., Honda M., and Hazama S. A study on the therapy of leprosy with an extract from tubercle bacilli. Jpn. J. Dermatol. 74 (1964) 174-178
39. Kobatake H., Suekane T., Murakami Y., Niwa S., Okahira A., and Kushida H. Studies on hot water extract of Mycobacterium tuberculosis: I. Structural analyses of polysaccharides. Yakugaku Zasshi 101 (1981) 713-722
40. Yin H., D'Souza F.W., and Lowary T.L. Arabinofuranosides from mycobacteria: synthesis of a highly branched hexasaccharide and related fragments containing β-arabinofuranosyl residues. J. Org. Chem. 67 (2002) 892-903
41. Joe M., Bai Y., Nacario R.C., and Lowary T.L. Synthesis of the docosanasaccharide arabinan domain of mycobacterial arabinogalactan and a proposed octadecasaccharide biosynthetic precursor. J. Am. Chem. Soc. 129 (2007) 9885-9901
42. Lafaille, C. (2007). Design of new fluorescent reporters for live cell imaging. M.Sc. thesis, University of Alberta, Alberta, Canada.
43. Krebber A., Bornhauser S., Burmester J., Honegger A., Willuda J., Bosshard H.R., and Pluckthun A. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J. Immunol. Methods 201 (1997) 35-55
44. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
45. Winn M.D. An overview of the CCP4 project in protein crystallography: an example of a collaborative project. J. Synchrotron Radiat. 10 (2003) 23-25
46. Read R.J. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr., Sect. D: Biol. Crystallogr. 57 (2001) 1373-1382
47. Winn M.D., Isupov M.N., and Murshudov G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr., Sect. D: Biol. Crystallogr. 57 (2001) 122-133
48. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 (2004) 2126-2132
49. Jeffrey G.A. Crystallographic studies of carbohydrates. Acta Crystallogr., Sect. B: Struct. Sci. 46 Pt 2 (1990) 89-103
50. Evdokimov A., Gilboa A.J., Koetzle T.F., Klooster W.T., Schultz A.J., Mason S.A., et al. Structures of furanosides: geometrical analysis of low-temperature X-ray and neutron crystal structures of five crystalline methyl pentofuranosides. Acta Crystallogr., Sect. B: Struct. Sci. 57 (2001) 213-220
51. Davis I.W., Leaver-Fay A., Chen V.B., Block J.N., Kapral G.J., Wang X., et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35 (2007) W375-W383
52. Morris A.L., MacArthur M.W., Hutchinson E.G., and Thornton J.M. Stereochemical quality of protein structure coordinates. Proteins 12 (1992) 345-364
53. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, San Carlos, CA